Elevance Health, Inc. (ELV) reaffirms 2025 EPS guidance and reports strong Q1 performance, despite Medicare audit concerns. ELV stock up 6.39% premarket.
Elevance Health, Inc. (ELV) reaffirms 2025 EPS guidance and reports strong Q1 performance, despite Medicare audit concerns. ELV stock up 6.39% premarket.